Our latest Neuro Pathways podcast explores observed gender differences in PD and shares how we’re using a novel female-tailored patient questionnaire to better understand the disease in women.
Read MoreThe Case for a Precision Medicine Approach to Training Epilepsy Clinicians
We explain why we’ve launched an Epilepsy Precision Medicine Fellowship and how it’s designed to empower tomorrow’s epileptologists to apply neurogenetics to improve patient care
Managing Refractory Hypocalcemia in an Asymptomatic Patient During Pregnancy
A patient presented with refractory, severe and also asymptomatic hypocalcemia at 20 weeks of gestation. Medical geneticist and nephrologist Xiangling Wang, MD, PhD, discusses management and reveals the outcome.
Who Will Respond to Migraine Preventive Therapy? Clinical-Genetic Research Collaborative Aims to Find Out
Interdisciplinary researchers are developing a model to predict patients’ response to costly CGRP-inhibiting monoclonal antibodies by pairing a polygenic risk score with demographic and clinical factors.
New Research Collaborative Aims to Close Minority Health Disparities
Cleveland Clinic researchers are organizing the Latino Epidemiology Cohort, a consortium that will investigate disease causes, risk and outcomes in underrepresented communities, initially focusing on Parkinson’s disease and colorectal cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Prediction Model Aids in the Early Diagnosis of Dravet Syndrome
The tool’s utility in distinguishing Dravet syndrome from milder genetic epilepsies promises earlier intervention to attenuate risk of cognitive effects in the youngest children.
Launch of Cleveland Clinic Brain Study Marks Unprecedented Effort to Disrupt Neurological Diseases
This landmark prospective investigation aims to study up to 200,000 healthy individuals over 20 years to identify brain disease biomarkers and targets for preventing and curing neurological disorders.
The Promise of Gene Therapy in Neurological Disorders (Podcast)
Our newest Neuro Pathways podcast episode spotlights advances in genomic research that show promise for targeted gene therapy for conditions from neurodegenerative diseases to epilepsy.
New Clinic Helps Cancer Patients Decipher Results of Genome Sequencing
New virtual genomics clinic provides custom-tailored cancer treatments by targeting specific molecular alterations in patients’ tumors.
Cleveland Clinic Expands Cancer Genomic Testing Capabilities
Cleveland Clinic now offers an advanced genomic testing platform as standard of care to patients with cancer. This expanded capability turns cancer treatment into a “stealth bullet” that allows clinicians to identify genetic defects and connect patients with individualized, lifesaving therapies.
Machine Learning Model Uses Clinical and Genomic Data to Predict Immune Checkpoint Blockade Effectiveness
A computer model developed by Cleveland Clinic oncologist Timothy Chan, MD, PhD, and colleagues accurately predicts whether immune checkpoint blockade will be effective in patients diagnosed with a wide variety of cancers.